| 000 | 01764 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513225204.0 | ||
| 264 | 0 | _c20010201 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0014-5793 | ||
| 024 | 7 |
_a10.1016/s0014-5793(00)02306-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrari, D | |
| 245 | 0 | 0 |
_aP2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production. _h[electronic resource] |
| 260 |
_bFEBS letters _cDec 2000 |
||
| 300 |
_a217-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aComplement C5a _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEosinophils _xcytology |
| 650 | 0 | 4 |
_aGuanosine Triphosphate _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Fluid _xmetabolism |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Agonists |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xchemistry |
| 650 | 0 | 4 |
_aUridine Triphosphate _xmetabolism |
| 700 | 1 | _aIdzko, M | |
| 700 | 1 | _aDichmann, S | |
| 700 | 1 | _aPurlis, D | |
| 700 | 1 | _aVirchow, C | |
| 700 | 1 | _aNorgauer, J | |
| 700 | 1 | _aChiozzi, P | |
| 700 | 1 | _aDi Virgilio, F | |
| 700 | 1 | _aLuttmann, W | |
| 773 | 0 |
_tFEBS letters _gvol. 486 _gno. 3 _gp. 217-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-5793(00)02306-1 _zAvailable from publisher's website |
| 999 |
_c11060323 _d11060323 |
||